Douglas A. Jabs
American ophthalmologist, born 1951, Elmire, New York
Biography of Douglas A. JabsDavid A. Jabs is an expert in clinical research in the fields of ophthalmology and uveitis. He is currently the Chief Executive Officer of the Mount Sinai Faculty Practice Associates, Dean for Clinical Affairs, and Professor and Chair of the Department of Ophthalmology and Professor of Medicine of The Mount Sinai School of Medicine in New York City. Additionally, he is adjunct Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.
Davis A. Jabs graduated valedictorian from Dartmouth College in 1973 with a degree in chemistry. He received his medical degree from Johns Hopkins University School of Medicine in 1977, and his M.D. from the same university. He served internships and residencies in medicine at
New York Hospital–Cornell Medical Center, The Johns Hopkins Hospital and Wilmer Eye Institute, as well as a rheumatology fellowship at Johns Hopkins.
Jabs joined the faculty at the Johns Hopkins School of Medicine in 1984 as Assistant Professor. He was named Associate Professor of Ophthalmology in 1988, and Associate Professor of Medicine in 1989. In 1993 he was named Professor of both Ophthalmology and Medicine, and in 2000 he was named Professor of Epidemiology at the Bloomberg School of Public Health. He received a Masters of Science in Business from The John Hopkins University in 1998, and a Masters of Business Administration from The Johns Hopkins in 2000. He became Chairman of Ophthalmology at the Mount Sinai School of Medicine in March 2007.
Jabs currently chairs both the Study of Ocular Complications of AIDS (SOCA) Research Group and the Multicenter Uveitis Steroid Treatment (MUST) Trial. He has chaired five randomized, controlled, clinical trials on the treatment of CMV retinitis and now chairs a multicenter epidemiologic study investigating the long–term outcomes of patients with ocular complications of AIDS, particularly CMV retinitis. Jabs has been instrumental in leading the Standardization of Uveitis (SUN) project, an effort to standardize terminology and outcomes related to uveitis. He has served on numerous data and safety monitoring committees for clinical trials, both those sponsored by the National Institutes of Health and the pharmaceutical industry.
David A. Jabs is affiliated with several scientific bodies and societies and has received numerous awards.
Jabs is the author or co–author of over 230 publications, 45 books chapters and 86 published abstracts.
• Information from Wikipedia